We’ve arrived in Hobart! To kick things off, the ANZSA Scientific Advisory Committee is meeting to discuss recent research developments and explore future directions. It’s wonderful to see sarcoma specialists and consumers from across Australia and New Zealand collaborating. #ANZSAASM2025

Thank you to our Board Director Dr Vivek Bhadri and our Scientific Advisor A/Prof Jeremy Lewin for contributing their expertise to our 2025 Sarcoma Awareness Month campaign through their interview with Australian Health Journal. Watch their interview: youtu.be/kMtmJaqPPHs?...

Join us for our first #SarcomaAwarenessMonth webinar in collaboration with @vcccalliance.bsky.social. Register here: vcccalliance.org.au/news-and-eve...

📢 The Provisional Program for the ANZSA Annual Scientific Meeting is now available. Take a look at the planned sessions and speakers, and don’t forget to register to attend. View the program here: sarcoma.org.au/pages/2025-a...

Abstract submissions are now open for the 2025 ANZSA Annual Scientific Meeting. We’re inviting poster submissions from all areas of sarcoma research! Deadline: Friday 1 August 2025 (midnight AEST) 📎 Follow the submission instructions at: aoa.org.au/events/cem-e...

Join leading minds in sarcoma research and care at the 2025 ANZSA Annual Scientific Meeting, October 10–11 in Hobart. Connect with clinicians, researchers, and advocates to explore the latest in sarcoma science and multidisciplinary care. Register today: sarcoma.org.au/pages/2025-a...

TODAY! Please join us today for the second virtual ANZSA Sarcoma Journal Club of 2025. When: Wednesday, 30 April, 5pm - 6pm AEST Host: Dr. Susie Bae (Peter MacCallum Cancer Centre) Register here: forms.office.com/r/VLjFP39QPP

We're proud to announce that ANZSA Clinical Fellow @lizconnolly.bsky.social is leading an international effort on the clinical management of sarcoma and genetic predisposition syndromes, recently published in @thelancet.bsky.social. Congratulations Liz! Read here: sarcoma.org.au/pages/resear...

A/Prof Sarat Chander’s paper on automated planning for Lattice Radiation Therapy has been named one of the top 10% most-viewed papers of 2023 by Medical Physics. Part-funded by ANZSA, this groundbreaking work paves the way for more efficient, consistent treatment of complex tumours!

ANZSA is excited to join BlueSky! We look forward to raising awareness, sharing knowledge, and connecting with you all to improve outcomes for sarcoma patients through research and education. 🦋💛